Blastocystis hominis, previously known as a yeast, is being considered a potential pathogenic protozoan by different authors (RR Babb & S Wagener 1989 West J Med 151: 518-519, SMH Qadri et al. 1989 J Clin Microbiol 27: 2407 -2409 . However, others believe it to be a commensal microorganism (T Sun et al. 1989 Am J Gastroenterol 84: 1543 -1547 , H Senay & D Mac Pherson 1990 .
There are many reports that show the possibility of this microorganism to cause gastrointestinal disorders in patients with immunodeficiency diseases (PL Garavelli et al. 1988 Lancet ii: 1364 , JM Llibre et al. 1989 Lancet ii: 221, PL Garavelli & M Libanore 1990 . We present here the results of a coproparasitological study carried out in Cuban AIDS patients in whom the prevalence of B. hominis infection had never been studied.
During the period of September 1994 to January 1995, at least two fecal samples were obtained from 67 adult AIDS patients who were admitted in our hospital due to different diseases; all of them were infected with the human immunodeficiency virus (HIV) and met the Centers for Disease Control (CDC) criteria for AIDS (CDC 1987 MMWR 36: 1-15) ; the totality of stool samples were examined immediately upon arrival and were processed in the intestinal parasite laboratory at Tropical Medicine Institute "Pedro Kourí" in Havana. This protozoan is a frequently occurring microorganism in fecal samples of patients with gastrointestinal tract disorders and it has been described as a causative agent of these problems (JB Vanata et al. 1985 Ann Intern Med 102: 495-496, MC Henry et al. 1986 . However, we think B. hominis has a commensal behaviour due to the lack of association with gastrointestinal disorders when we compared the group of AIDS patients infected with B. hominis, with the rest of AIDS patients in whom this microorganism was not found. Other reason for that conclusion was the finding of a reduced number of microorganisms found per field, besides, according to Sheehan's criteria, they could not be taken as cases of blastocystosis (DR Sheehan et al. 1986 J Clin Microbiol 24: 548-550) . For those cases who developed diarrhoea we suspected the possibility of viral, bacterial, fungal, or microsporidial intestinal coinfections not detectable in our study design. It is important to realize that all these AIDS patients were kept at hospital facilities suffering of different diseases, they underwent antimicrobial therapy, consequently they could have developed a cross protection against this protozoan. In this sense the study performed by AN Cohen et al. (1985 Ann Intern Med 103: 480-481) could be a good example, when they used ketoconazole as an alternative drug for B. hominis treatment, and it is very well known that this drug is one of the most employed in oral candidiasis treatment, a very frequent infection in AIDS patients.
As a conclusion, our results suggest that B. hominis is common in AIDS patients in Cuba but its role as an enteropathogen in these patients remains uncertain so far.
